Cargando…
Augmentation of Docetaxel-Induced Cytotoxicity in Human PC-3 Androgen-Independent Prostate Cancer Cells by Combination With Four Natural Apoptosis-Inducing Anticancer Compounds
Docetaxel (DTX) is the treatment of choice for metastatic castration-resistant prostate cancer. However, developing drug resistance is a significant challenge for achieving effective therapy. This study evaluated the anticancer and synergistic effects on DTX of four natural compounds (calebin A, 3(′...
Autores principales: | Ahmed, Inass A, Hafiz, Saly, van Ginkel, Sabrina, Pondugula, Satyanarayana R, Abdelhaffez, Azza S, Sayyed, Hayam G, El-Aziz, Ebtihal A Abd, Mansour, Mahmoud M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249917/ https://www.ncbi.nlm.nih.gov/pubmed/37292146 http://dx.doi.org/10.1177/1934578x231175323 |
Ejemplares similares
-
The Combination of Omega-3 Stearidonic Acid and Docetaxel Enhances Cell Death over Docetaxel Alone in Human Prostate Cancer Cells
por: Mansour, Mahmoud, et al.
Publicado: (2018) -
Serum Procalcitonin in Patients With Combined Lung Cancer and Idiopathic Pulmonary Fibrosis (LC-IPF)
por: Mohamed, Sherif, et al.
Publicado: (2020) -
Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line
por: Cancino-Marentes, Martha E., et al.
Publicado: (2021) -
Is COVID-19 Similar in Pregnant and Non-Pregnant Women?
por: Selim, Mohamed, et al.
Publicado: (2020) -
Incidence and pathophysiologic mechanisms of stroke in the COVID-19 pandemic: the dilemma
por: Mohamed, Sherif, et al.
Publicado: (2020)